December 9, 2020 Regulatory Notice of Extraordinary General Meeting in InDex Pharmaceuticals Holding AB Read more
December 9, 2020 Regulatory InDex Pharmaceuticals Holding AB kallar till extra bolagsstämma Read more
December 3, 2020 Non Regulatory InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2021 Annual General Meeting Read more
December 3, 2020 Non Regulatory InDex Pharmaceuticals Holding AB (publ) offentliggör valberedning inför årsstämman 2021 Read more
November 26, 2020 Non Regulatory InDex Pharmaceuticals to host virtual R&D day on December 8, 2020 Read more
November 26, 2020 Non Regulatory InDex Pharmaceuticals arrangerar virtuell FoU-dag den 8 december 2020 Read more
November 25, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – September 2020 Read more
November 25, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – september 2020 Read more
November 25, 2020 Regulatory InDex Pharmaceuticals intends to carry out a fully guaranteed rights issue of approximately SEK 500 million to fund phase III development of cobitolimod Read more
November 25, 2020 Regulatory InDex Pharmaceuticals avser att genomföra en fullt garanterad företrädesemission om cirka 500 miljoner kronor för att finansiera fas III-utveckling av cobitolimod Read more
November 24, 2020 Non Regulatory InDex Pharmaceuticals presents at Redeye Life Science Day 2020 Read more
November 24, 2020 Non Regulatory InDex Pharmaceuticals presenterar på Redeye Life Science Day 2020 Read more
October 6, 2020 Non Regulatory Lancet Gastroenterology and Hepatology publicerar resultaten från InDex Pharmaceuticals fas IIb-studie med cobitolimod Read more
October 6, 2020 Non Regulatory The Lancet Gastroenterology and Hepatology publishes InDex Pharmaceuticals’ results of the phase IIb study with cobitolimod Read more
August 26, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – juni 2020 Read more
August 26, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – June 2020 Read more
August 24, 2020 Non Regulatory InDex Pharmaceuticals to present the successful results of the CONDUCT study at two leading medical conferences Read more
August 24, 2020 Non Regulatory InDex Pharmaceuticals presenterar de positiva resultaten från CONDUCT-studien vid två ledande medicinska konferenser Read more
May 7, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – March 2020 Read more
May 7, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – mars 2020 Read more
April 20, 2020 Regulatory Bulletin from the Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more
April 20, 2020 Regulatory Kommuniké från årsstämma i InDex Pharmaceuticals Holding AB (publ) Read more
April 16, 2020 Regulatory InDex Pharmaceuticals advances cobitolimod further towards phase III following successful interactions with FDA and EMA Read more
April 16, 2020 Regulatory FDA och EMA ger klartecken för InDex Pharmaceuticals att ta cobitolimod vidare till fas III Read more
April 8, 2020 Non Regulatory Update on InDex Pharmaceuticals Holding AB’s (InDex) Annual General Meeting addressing covid-19 Read more
April 8, 2020 Non Regulatory Information om InDex Pharmaceuticals Holding AB’s (InDex) årsstämma 2020 med anledning av covid-19 Read more
March 31, 2020 Non Regulatory InDex Pharmaceuticals receives grant from Vinnova for pre-clinical development of DIMS compounds in inflammation Read more
March 31, 2020 Non Regulatory InDex Pharmaceuticals får finansiering från Vinnova för preklinisk utveckling av DIMS-substanser mot inflammatoriska sjukdomar Read more
March 30, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2019 Read more
March 30, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) offentliggör årsredovisning för 2019 Read more
March 19, 2020 Regulatory Notice to attend the Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more
February 25, 2020 Non Regulatory InDex Pharmaceuticals publishes mechanism of action data for cobitolimod in scientific journal Read more
February 25, 2020 Non Regulatory InDex Pharmaceuticals publicerar data om cobitolimods verkningsmekanism i vetenskaplig tidskrift Read more
February 20, 2020 Regulatory InDex Pharmaceuticals Holding AB (publ) bokslutskommuniké 2019 Read more
February 19, 2020 Regulatory InDex Pharmaceuticals’ in-depth analysis of the CONDUCT study confirms the successful top line results and supports the strategy going forward Read more
February 19, 2020 Regulatory InDex Pharmaceuticals fördjupade analys av CONDUCT-studien bekräftar de starka huvudresultaten och stödjer strategin framåt Read more